GL1X · GenesisL1 explorer

MolNFT v1 · #69605 · protein

Crystal structure of the I93M mutant of ubiquitin carboxy terminal hydrolase L1 bound to ubiquitin vinylmethylester

3KVF · Ubiquitin carboxyl-terminal hydrolase isozyme L1: “Crystal structure of the I93M mutant of ubiquitin carboxy terminal hydrolase L1 bound to ubiquitin…”. X-ray diffraction, 1 ligand (GVE), 1 pocket (best druggability 0.30). MolNFT v1…

PDB
3KVF
Type
protein
Length
298 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ubiquitin carboxyl-terminal hydrolase isozyme L1; Ubiquitin
EC
3.4.19.12, 6.-.-.-
UniProt
P09936, P62988
Ligands
GVE
Pockets
1 · best druggability 0.30

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUbiquitin carboxyl-terminal hydrolase isozyme L1 (EC 3.4.19.12, 6.-.-.-)protein22337% helix, 20% strandP09936
BUbiquitinprotein7524% helix, 36% strandP62988

Ligands and binding sites

  • GVE · Methyl 4-aminobutanoate · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1600.300.7518empty

Interfaces

1 interface between chains.

  • A–B · 1178 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 3KVF · Crystal structure of the I93M mutant of ubiquitin carboxy terminal hydrolase L1 bound to… · the same entry in another collection · chain A against A, TM-score 1.00
  • P09936 · AlphaFold monomer V2.0 prediction for ubiquitin carboxyl-terminal hydrolase isozyme L1… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.